Critical Care Suite with Pneumothorax Detection AI Algorithm, Critical Care Suite 2.1, Critical Care Suite

K223491

GE Medical Systems, LLC · cleared 2023-05-25 · product code QBS · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.3)
Critical Care Suite with Pneumothorax Detection AI Algorithm is a computer-aided triage, notification, and diagnostic device that analyzes frontal chest X-ray images for the presence of a pneumothorax. Critical Care Suite is a software module that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or X-ray Imaging Systems.
Algorithmdeep learning AI algorithms
source quote (p.6)
They are all deep learning locked AI algorithms that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or X-ray Imaging Systems.
Adaptive (vs locked)No
source quote (p.6)
They are all deep learning locked AI algorithms that can be deployed on several computing platforms such as PACS, On Premise, On Cloud or X-ray Imaging Systems.
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (2)

Retrospective clinical

n=804 images · 2 site(s)

endpoints: detection of pneumothorax; localization of suspected pneumothorax

Reader study (MRMC)

n=400 images

endpoints: improved reader performance for detection of pneumothorax

Reported performance (7 observations)

sensitivity0.843CI 80.6%, 88.0%
source quote (p.8)
a sensitivity of 84.3% (80.6%, 88.0%)
specificity0.932CI 90.8%, 95.6%
source quote (p.8)
and a specificity of 93.2% (90.8%, 95.6%)
aurocas written: “auc0.961CI 94.9%, 97.2%
source quote (p.8)
The Pneumothorax Detection AI Algorithm achieved an AUC of 96.1% (94.9%, 97.2%)
sensitivityas written: “Sensitivity for large pneumothoraxes0.963CI 93.1%, 99.2%
source quote (p.8)
The algorithm also had high sensitivity for detecting large pneumothoraxes with a sensitivity of 96.3% (93.1%, 99.2%)
sensitivityas written: “Sensitivity for small pneumothorax0.75CI 69.2%, 80.8%
source quote (p.8)
and small pneumothorax with a sensitivity of 75.0% (69.2%, 80.8%).
agreement_kappaas written: “Full agreement between regions for Pneumothorax Overlay0.678CI 62.7%, 73.0%
source quote (p.8)
It performed with full agreement between these regions 67.8% (62.7%, 73.0%).
diceas written: “DICE Similarity Coefficient for Pneumothorax Overlay0.705CI 0.683, 0.724)
source quote (p.8)
It also performed with a DICE Similarity Coefficient of 0.705 (0.683, 0.724) indicating that on average 70.5% of the Pneumothorax Overlay area and the true area of a pneumothorax within an image overlap.

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
0
drift signals on this device

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K223491